In the past decade, there have been growing efforts through state and local legislations to shift from criminalizing drug abuse to treating it as a health condition requiring medical intervention. 9 states have legislations for safe syringe use like exchange programs or purchasing at pharmacy. In addition, AB-186 Controlled substances: overdose prevention program was introduced to operate safe injection sites in the City and County of San Francisco. The bill was vetoed on September 30, 2018 by California Governor Jerry Brown. The legality of these sites are still in discussion, so there are no such sites in the United States yet. However, there is growing international evidence for successful safe injection facilities.
Dangerous behaviors common among alcoholics include impaired judgment and coordination, falling asleep at the wheel, falling asleep with lit cigarettes, aggressive outbursts, drinking to the point of vomiting, hangover, or alcohol poisoning — and these are just the ones most alcoholics experience in the course of their disease. All of these behaviors will eventually hit the system, in the form of health care costs, criminal justice costs, motor vehicle crash costs, and workplace productivity
Rock Solid Recovery (men’s rehab) and its sister center, Sure Haven (women’s rehab), are highly rated, intimate treatment facilities. Treatment is based on a holistic, 12-step approach. Each facility has its own complete, multidisciplinary treatment staff, allowing patients to receive the best individualized care possible. The facilities offer inpatient treatment programs ranging from 30 days to 90 days, depending on patient needs. The primary benefit of these treatment centers is their small size. The men’s facility supports 6 patients and the women’s supports 13. This allows for the specialized, highly successful treatment that these facilities are known for.
“There is no conclusive evidence that the drug effects of marijuana are causally linked to the subsequent abuse of other illicit drugs,” states the National Academy of Sciences’ Institute of Medicine. The Institute goes on to assert that underage smoking and alcohol use seem to better fit the profile of gateway drugs. The Institute points out that nicotine and alcohol typically precede marijuana use. This may be true by virtue of the fact that cigarettes and beer are often easier to obtain than marijuana.
The Diagnostic and Statistical Manual of Mental Disorders (DSM) once referred to substance abuse and substance dependence as diagnostic terms. However, in the updated fifth edition (DSM-5), these terms are replaced by the singular substance use disorder, which is broken into mild, moderate and severe to refer to the physical and mental impairments through recurrent substance use.
In his influential book, Client-Centered Therapy, in which he presented the client-centered approach to therapeutic change, psychologist Carl Rogers proposed there are three necessary and sufficient conditions for personal change: unconditional positive regard, accurate empathy, and genuineness. Rogers believed the presence of these three items, in the therapeutic relationship, could help an individual overcome any troublesome issue, including but not limited to alcohol abuse. To this end, a 1957 study compared the relative effectiveness of three different psychotherapies in treating alcoholics who had been committed to a state hospital for sixty days: a therapy based on two-factor learning theory, client-centered therapy, and psychoanalytic therapy. Though the authors expected the two-factor theory to be the most effective, it actually proved to be deleterious in the outcome. Surprisingly, client-centered therapy proved most effective. It has been argued, however, these findings may be attributable to the profound difference in therapist outlook between the two-factor and client-centered approaches, rather than to client-centered techniques. The authors note two-factor theory involves stark disapproval of the clients' "irrational behavior" (p. 350); this notably negative outlook could explain the results.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)